At a glance
- Originator Solural Pharma
- Class Alkaloids; Antineoplastics; Camptothecins; Small molecules
- Mechanism of Action DNA topoisomerase I inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase I Colorectal cancer
Most Recent Events
- 15 Mar 2016 Biomarkers information updated
- 08 Dec 2015 Phase-I clinical trials in Colorectal cancer in Denmark (PO) prior to December 2015 (Solural Pharma pipeline, December 2015)